Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS060926, 1R01NS091159)
Muscular Dystrophy Association (MDA418685)
- License Information
-
More Information
Article History
Received: 24 January 2019
Accepted: 15 March 2019
First Online: 18 April 2019
Competing Interests
: Dr. Rutkove serves as scientific advisor and consultant to Myolex, Inc., a company that commercializes impedance technology. Dr. Rutkove is also a member of the company’s Board of Directors. Dr. Sanchez serves as a consultant to Myolex, Inc., and Impedimed, Inc., a company that develop impedance technology for research and clinical use. Dr. Sanchez and Dr. Rutkove are Co-Founders of Haystack Diagnostics, Inc., a company that commercializes needle impedance technology. Haystack Diagnostics, Inc., has the option to license patented needle impedance technology of which Dr. Sanchez and Dr. Rutkove are named inventors.
